SHP-1在Ang-(1-7)拮抗AngⅡ致心房肌缝隙连接蛋白43重构中的作用

柳逸豪; 鲁力; 曹黎; 陈芸霖; 王耀文; 范晋奇; 殷跃辉

doi:10.16016/j.1000-5404.201801240

您当前的位置：

首页 >

文章列表页 >

SHP-1在Ang-(1-7)拮抗AngⅡ致心房肌缝隙连接蛋白43重构中的作用

基础医学 | 更新时间：2026-01-09

- SHP-1在Ang-(1-7)拮抗AngⅡ致心房肌缝隙连接蛋白43重构中的作用
- Role of SHP-1 in angiotensin- (1-7) antagonizing angiotensin Ⅱ-induced connexin remodeling in mouse HL-1 cardiomyocytes
- 第三军医大学学报 2018年40卷第13期页码：1179-1184
- 作者机构：
  
  400010 重庆，重庆医科大学附属第二医院心血管内科
- 作者简介：
  
  [范晋奇，E-mail：wuyu0506@126.com FAN Jinqi, E-mail: wuyu0506@126.com
- 基金信息：
  
  国家自然科学基金面上项目(81570302);国家自然科学基金青年科学基金项目(81500250)
- DOI：10.16016/j.1000-5404.201801240
  中图分类号： R322.11;R329-33;R329.28
- 收稿：2018-01-25，
  
  修回：2018-04-03，
  
  纸质出版：2018-07-15
- 稿件说明：
移动端阅览
柳逸豪, 鲁力, 曹黎, 等. SHP-1在Ang-(1-7)拮抗AngⅡ致心房肌缝隙连接蛋白43重构中的作用[J]. 第三军医大学学报, 2018,40(13):1179-1184.

Yihao LIU, Li LU, Li CAO, et al. Role of SHP-1 in angiotensin- (1-7) antagonizing angiotensin Ⅱ-induced connexin remodeling in mouse HL-1 cardiomyocytes[J]. Journal of Third Military Medical University, 2018, 40(13): 1179-1184.
柳逸豪, 鲁力, 曹黎, 等. SHP-1在Ang-(1-7)拮抗AngⅡ致心房肌缝隙连接蛋白43重构中的作用[J]. 第三军医大学学报, 2018,40(13):1179-1184. DOI： 10.16016/j.1000-5404.201801240.

Yihao LIU, Li LU, Li CAO, et al. Role of SHP-1 in angiotensin- (1-7) antagonizing angiotensin Ⅱ-induced connexin remodeling in mouse HL-1 cardiomyocytes[J]. Journal of Third Military Medical University, 2018, 40(13): 1179-1184. DOI： 10.16016/j.1000-5404.201801240.

摘要

目的

探讨血管紧张素1-7[angiotensin 1-7，Ang-(1-7)]是否通过SHP-1来抑制血管紧张素Ⅱ(angiotensin Ⅱ，AngⅡ)诱导的c-Src激活，从而改善缝隙连接蛋白43(connexin 43，Cx43)的表达以及功能。

方法

以小鼠心房肌细胞系(HL-1细胞系)作为研究对象，分为Control组、AngⅡ组、AngⅡ+SU6656(c-Src抑制剂)组、AngⅡ+Ang-(1-7)组、AngⅡ+Ang-(1-7)+SSG (SHP-1抑制剂)组，Western blot分别检测p-c-Src、Cx43、SHP-1的表达，细胞免疫荧光、划痕标记染料示踪技术观察Cx43空间分布以及缝隙连接功能。

结果

与Control组比较，高浓度AngⅡ(10

-6

mol/L)干预后p-c-Src表达增加(

＜0.01)，Cx43表达降低(

＜0.05)，Cx43传导距离缩短；SU6656和Ang-(1-7)预处理可抑制AngⅡ诱导的c-Src激活，Cx43表达增加(

＜0.05)，Cx43传导距离增加；同时Ang-(1-7)预处理明显地促进SHP-1的表达增加(

＜0.05)。与AngⅡ+Ang-(1-7)组比较，AngⅡ+Ang-(1-7)+SSG组SHP-1表达降低(

＜0.05)，p-c-Src表达增加(

＜0.01)，细胞Cx43表达降低(

＜0.05)，Cx43传导距离缩短。

结论

Ang-(1-7)通过增加SHP-1表达从而抑制c-Src活性，进而发挥对AngⅡ的拮抗作用，使Cx43表达上升并改善缝隙连接功能。

Abstract

Objective

To investigate whether angiotensin 1-7 [Ang-(1-7)] inhibits angiotensin Ⅱ (AngⅡ)-induced c-Src activation through SHP-1

and thereby improves Cx43 expression and function.

Methods

Mouse HL-1 cardiomyocytes were treated respectively by AngⅡ

AngⅡ+SU6656 (a specific c-Src inhibitor)

AngⅡ+Ang-(1-7)

and AngⅡ+Ang-(1-7)+SSG (a specific SHP-1 inhibitor)

and those without any treatment served as control cells. Western blotting was used to detect the expression levels of p-c-Src

Cx43 and SHP-1 in these cells. Cell immunofluorescence staining and scrape-loading and dye transfer (SLDT) tracing were employed to observe the spatial distribution of Cx43 and the function of gap junctions.

Results

Compared with the control cells

higher concentration of AngⅡ (10-6 mol/L) treatment increased the expression of p-c-Src (

0.01)

but inhibited the expression of Cx43 (

0.05) and shortened the conduction distance of gap junction. While

Ang-(1-7)+SU6656 pretreatment inhibited the activation of c-Src induced by AngⅡ (

0.05)

enhanced the expression of Cx43 and shorten the conduction distance of gap junction. At the same time

Ang-(1-7) precondition effectively enhanced the expression of SHP-1 (

0.05). Compared with the AngⅡ+Ang-(1

-7) treated cells

AngⅡ+Ang-(1-7)+SSG significantly inhibited SHP-1 expression (

0.05)

increased that of p-c-Src (

0.01) and decreased Cx43 expression (

0.05).

Conclusion

Ang-(1-7) inhibits c-Src activity by increasing the expression of SHP-1

thereby exerts an antagonistic effect on AngⅡ

and then results in the up-regulation of Cx43 and improvement of gap junction function.

关键词

Keywords

references

KIM E, FISHMAN G I. Designer gap junctions that prevent cardiac arrhythmias[J]. Trends Cardiovasc Med, 2013, 23(2): 33-38. DOI:10.1016/j.tcm.2012.08.008.

OSBOURNE A, CALWAY T, BROMAN M, et al. Down-regulation of connexin43 by microRNA-130a in cardiomyocytes results in cardiac arrhythmias[J]. J Mol Cell Cardiol, 2014, 74:53-63.DOI:10.1016/j.yjmcc.2014.04.024.

SEKI A, NISHII K, HAGIWARAN. Gap junctional regulation of pressure, fluid force, and electrical fields in the epigenetics of cardiac morphogenesis and remodeling[J]. Life Sci, 2015, 129:27-34. DOI:10.1016/j.lfs.2014.10.022.

RUDOLPH T K, RAVEKES T, KLINKE A, et al. Nitrated fatty acids suppress angiotensin Ⅱ-mediated fibrotic remodelling and atrial fibrillation[J]. Cardiovasc Res, 2016, 109(1): 174-184. DOI:10.1093/cvr/cvv254.

YASUNO S, KUWAHARA K, KINOSHITA H, et al. Angiotensin Ⅱ type 1a receptor signalling directly contributes to the increased arrhythmogenicityin cardiac hypertrophy[J]. Br J Pharmacol, 2013, 170(7): 1384-1395. DOI:10.1111/bph.12328.

KLINE C L, OLSON T L, IRBY R B. Src activity alters alpha3 integrin expression in colon tumor cells[J]. Clin Exp Metastasis, 2009, 26(2): 77-87. DOI:10.1007/s10585-008-9215-x.

HOSSAIN E, ANAND-SRIVASTAVA M B. Resveratrol prevents angiotensin Ⅱ-induced hypertrophy of vascular smooth muscle cells through the transactivation of growth factor receptors[J]. Can J Physiol Pharmacol, 2017, 95(8):945-953. DOI:10.1139/cjpp-2017-0164.

JIANG F, YANG J, ZHANG Y, et al. Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets[J]. Nat Rev Cardiol, 2014, 11(7): 413-426.DOI:10.1038/nrcardio.2014.59.

TAO X, FAN J, KAO G, et al. Angiotensin-(1-7) attenuates angiotensin Ⅱ-induced signalling associated with activation of a tyrosine phosphatase in Sprague-Dawley rats cardiac fibroblasts[J]. Biol Cell, 2014, 106(6): 182-192.DOI:10.1111/boc.201400015.

SAMPAIO W O, HENRIQUEDECASTRO C, SANTOS R A, et al. Angiotensin-(1-7) counterregulates angiotensin Ⅱ signaling in human endothelial cells[J]. Hypertension, 2007, 50(6): 1093-1098. DOI:10.1161/HYPERTENSIONAHA.106.084848.

HEIJMAN J, VOIGT N, NATTEL S, et al. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression[J]. Circ Res, 2014, 114(9): 1483-1499.DOI:10.1161/CIRCRESAHA.114.302226.

HU Y F, CHEN Y J, LIN Y J, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol, 2015, 12(4): 230-243.DOI:10.1038/nrcardio.2015.2.

SOVARI A A, RUTLEDGE C A, JEONG E M, et al. Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death[J]. Circ Arrhythm Electrophysiol, 2013, 6(3): 623-631.DOI:10.1161/CIRCEP.112.976787.

SCHOTTEN U, VERHEULE S, KIRCHHOF P, et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal[J]. Physiol Rev, 2011, 91(1): 265-325.DOI:10.1152/physrev.00031.2009.

SOVARI A A, IRAVANIAN S, DOLMATOVA E, et al. Inhibition of c-Src tyrosine kinase prevents angiotensin Ⅱ-mediated connexin-43 remodeling and sudden cardiac death[J]. J Am Coll Cardiol, 2011, 58(22): 2332-2339.DOI:10.1016/j.jacc.2011.07.048.

RUTLEDGE C A, NG F S, SULKIN M S, et al. c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction[J]. J Am Coll Cardiol, 2014, 63(9): 928-934. DOI:10.1016/j.jacc.2013.10.081.

DU H, FAN J, LING Z, et al. Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients[J]. Hypertension, 2013, 61(4): 786- 792.DOI:10.1161/HYPERTENSIONAHA.111.202309.

GAVA E, SAMAD-ZADEH A, ZIMPELMANN J, et al. Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells[J]. Nephrol Dial Transplant, 2009, 24(6): 1766-1773.DOI:10.1093/ndt/gfn736.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Sirt4在心肌细胞中增强血管紧张素Ⅱ对GATA结合蛋白4的激活作用

血管紧张素1-7对血管紧张素Ⅱ诱导的SD大鼠心室成纤维细胞的影响

血管内皮生长因子通过缝隙连接蛋白43调节内皮祖细胞增殖迁移

重组血管紧张素（1-7）基因转染对大鼠急性心肌梗死后细胞外基质重构的影响

缝隙连接蛋白43在七氟醚后处理保护大鼠离体心肌缺血再灌注中的作用